AdvaMed represents 97 percent of the country’s devicemakers.
The group spent $1.75 million on lobbying in the fourth quarter of 2019, nearly tripling the amount it spent in the third quarter.
The lobbying push was in large part due to the medical device tax, which the industry has been trying to get Congress to repeal for years. The industry worried that impeachment would get in the way of Congress repealing the tax.
The tax was created as part of the Affordable Care Act and put a 2.3 percent levy on most of the medical devices sold in the U.S. It was set to go back into effect Jan. 1, after being suspended since 2015.
The tax was repealed Dec. 19 as part of a $1.4 trillion year-end spending deal.
More articles on supply chain:
Cardinal Health recalls 9 million surgical gowns
Devicemaker broke $2.1B contract to provide VA hospitals with critical medical supplies, lawsuit alleges
Reva Medical files for bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
